Cargando…

Pharmacogenomics in Pediatric Oncology: Review of Gene—Drug Associations for Clinical Use †

During the 3rd congress of the European Society of Pharmacogenomics and Personalised Therapy (ESPT) in Budapest in 2015, a preliminary meeting was held aimed at establishing a pediatric individualized treatment in oncology and hematology committees. The main purpose was to facilitate the transfer an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mlakar, Vid, Huezo-Diaz Curtis, Patricia, Satyanarayana Uppugunduri, Chakradhara Rao, Krajinovic, Maja, Ansari, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037779/ https://www.ncbi.nlm.nih.gov/pubmed/27618021 http://dx.doi.org/10.3390/ijms17091502

Ejemplares similares

The Association of Combined GSTM1 and CYP2C9 Genotype Status with the Occurrence of Hemorrhagic Cystitis in Pediatric Patients Receiving Myeloablative Conditioning Regimen Prior to Allogeneic Hematopoietic Stem Cell Transplantation
por: Uppugunduri, Chakradhara Rao S., et al.
Publicado: (2017)

A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation
por: Robin, Shannon, et al.
Publicado: (2022)

Correction to: A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation
por: Robin, Shannon, et al.
Publicado: (2022)

Development and validation of an allele-specific PCR assay for genotyping a promoter and exonic single nucleotide polymorphisms of MGMT gene
por: Tyagi, Anuj Kumar, et al.
Publicado: (2018)

Commentary: A Myriad Aberrations on Information of Ontogeny of Drug Metabolizing Enzymes in the Pediatric Population: An Obstacle for Personalizing Drug Therapy in the Pediatric Population
por: Uppugunduri, Chakradhara Rao S., et al.
Publicado: (2016)

Correction to: GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation
por: Jurkovic Mlakar, Simona, et al.
Publicado: (2021)

GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation
por: Jurkovic Mlakar, Simona, et al.
Publicado: (2021)

GSTA1 diplotypes affect busulfan clearance and toxicity in children undergoing allogeneic hematopoietic stem cell transplantation: a multicenter study
por: Ansari, Marc, et al.
Publicado: (2017)

Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with Busulfan
por: Seydoux, Claire, et al.
Publicado: (2023)

Validation of SYBR Green based quantification assay for the detection of human Torque Teno virus titers from plasma
por: Tyagi, Anuj Kumar, et al.
Publicado: (2013)

Precision dosing of intravenous busulfan in pediatric hematopoietic stem cell transplantation: Results from a multicenter population pharmacokinetic study
por: Ben Hassine, Khalil, et al.
Publicado: (2021)

Association of CTH variant with sinusoidal obstruction syndrome in children receiving intravenous busulfan and cyclophosphamide before hematopoietic stem cell transplantation
por: Huezo-Diaz Curtis, P, et al.
Publicado: (2018)

The analysis of GSTA1 promoter genetic and functional diversity of human populations
por: Mlakar, Vid, et al.
Publicado: (2021)

Pediatric Therapeutic Drug Monitoring for Selective Serotonin Reuptake Inhibitors
por: Strawn, Jeffrey R., et al.
Publicado: (2021)

Association study of candidate DNA-repair gene variants and acute graft versus host disease in pediatric patients receiving allogeneic hematopoietic stem-cell transplantation
por: Uppugunduri, C. R. S., et al.
Publicado: (2021)

Role of Drug Transporters in Elucidating Inter-Individual Variability in Pediatric Chemotherapy-Related Toxicities and Response
por: Kamath, Ashwin, et al.
Publicado: (2022)

Influence of glutathione S-transferase gene polymorphisms on busulfan pharmacokinetics and outcome of hematopoietic stem-cell transplantation in thalassemia pediatric patients
por: Ansari, M, et al.
Publicado: (2016)

The Clinical Relevance of Pre-Formed Anti-HLA and Anti-MICA Antibodies after Cord Blood Transplantation in Children
por: Ansari, Marc, et al.
Publicado: (2013)

Relative Copy Number Variations of CYP2C19 in South Indian Population
por: Devendran, Anichavezhi, et al.
Publicado: (2012)

The Biological and Clinical Relevance of G Protein-Coupled Receptors to the Outcomes of Hematopoietic Stem Cell Transplantation: A Systematized Review
por: Golay, Hadrien, et al.
Publicado: (2019)

Impact of computerised physician order entry (CPOE) on the incidence of chemotherapy-related medication errors: a systematic review
por: Srinivasamurthy, Suresh Kumar, et al.
Publicado: (2021)

A review of the biological and clinical implications of RAS-MAPK pathway alterations in neuroblastoma
por: Mlakar, Vid, et al.
Publicado: (2021)

11q deletion in neuroblastoma: a review of biological and clinical implications
por: Mlakar, Vid, et al.
Publicado: (2017)

Pharmacogenomics in oncology care
por: Filipski, Kelly K., et al.
Publicado: (2014)

The implications of pharmacogenomics in oncology
por: Latimer, Jean J.
Publicado: (2023)

Genetic Predictors for Sinusoidal Obstruction Syndrome—A Systematic Review
por: Waespe, Nicolas, et al.
Publicado: (2021)

Prioritization of microRNA biomarkers for a prospective evaluation in a cohort of myocardial infarction patients based on their mechanistic role using public datasets
por: Venugopal, Priyanka, et al.
Publicado: (2022)

Electric pulses used in electrochemotherapy and electrogene therapy do not significantly change the expression profile of genes involved in the development of cancer in malignant melanoma cells
por: Mlakar, Vid, et al.
Publicado: (2009)

A systematic review of knowledge, attitude and practice of pharmacogenomics in pediatric oncology patients
por: Moore, Claire, et al.
Publicado: (2023)

Association of NUDT15 c.415C>T and FPGS 2572C>T Variants with the Risk of Early Hematologic Toxicity During 6-MP and Low-Dose Methotrexate-Based Maintenance Therapy in Indian Patients with Acute Lymphoblastic Leukemia
por: Kodidela, Sunitha, et al.
Publicado: (2020)

Pharmacogenomics of pediatric asthma
por: Gupta, Sarika, et al.
Publicado: (2010)

A novel integrative multi-omics approach to unravel the genetic determinants of rare diseases with application in sinusoidal obstruction syndrome
por: Waespe, Nicolas, et al.
Publicado: (2023)

PRIMA-1(MET)-induced neuroblastoma cell death is modulated by p53 and mycn through glutathione level
por: Mlakar, Vid, et al.
Publicado: (2019)

Dose Optimization in Oncology Drug Development: The Emerging Role of Pharmacogenomics, Pharmacokinetics, and Pharmacodynamics
por: Papachristos, Apostolos, et al.
Publicado: (2023)

Assessment of the tumourigenic and metastatic properties of SK-MEL28 melanoma cells surviving electrochemotherapy with bleomycin
por: Todorovic, Vesna, et al.
Publicado: (2012)

Communication of Pharmacogenomic test results and treatment plans in pediatric oncology: deliberative stakeholder consultations with parents
por: Longo, Cristina, et al.
Publicado: (2021)

Oncology and Pharmacogenomics Insights in Polycystic Ovary Syndrome: An Integrative Analysis
por: Yumiceba, Verónica, et al.
Publicado: (2020)

SYNERGxDB: an integrative pharmacogenomic portal to identify synergistic drug combinations for precision oncology
por: Seo, Heewon, et al.
Publicado: (2020)

ADRA2A is involved in neuro-endocrine regulation of bone resorption
por: Mlakar, Vid, et al.
Publicado: (2015)

Pharmacogenomics in Pediatric Patients: Towards Personalized Medicine
por: Maagdenberg, Hedy, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_pb7tuo3i9912u9e8scm354dr0q